# Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

> **NCT02565017** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 70 (actual)

## Conditions studied

- Breast Cancer
- Lung Cancer
- Colorectal Cancer

## Interventions

- **BEHAVIORAL:** Focus groups

## Key facts

- **NCT ID:** NCT02565017
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-15
- **Primary completion:** 2020-06-22
- **Final completion:** 2020-06-22
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02565017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02565017, "Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02565017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*